Aminoglycosides in the treatment of bacteraemic infections in the immuno-comprised host.
D000380:Agranulocytosis / Q000150:complications*; D000583:Amikacin / Q000627:therapeutic use; D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D009428:Netilmicin / Q000627:therapeutic use; D009503:Neutropenia / Q000150:complications*; D018805:Sepsis / Q000188:drug therapy*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D009428:Netilmicin; D000583:Amikacin